CA
NZ
UK
AU
IND
US
Director Alex G. Howarth filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of stock options covering 160,000 shares of Altimmune, Inc. common stock, with a transaction date of November 2, 2026.
Director Peter Greenleaf filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of stock options covering 160,000 shares of Altimmune, Inc. common stock, with a transaction date of November 2, 2026.
Peter Greenleaf, a newly appointed director at Altimmune, Inc., filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 4, 2026, disclosing no securities beneficially owned as of the event date of November 2, 2026.
Charles R. Schroeder filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 4, 2026, disclosing his beneficial ownership of Bandwidth Inc. securities upon his appointment as a director on October 28, 2026.
ARS Pharmaceuticals, Inc. Chief Legal Officer John L. Slebir filed a statement of changes in beneficial ownership on November 4, 2026, disclosing the acquisition of stock options on November 2, 2026.
An initial statement of beneficial ownership was filed on November 4, 2026, disclosing that Helen Jane Sheirbon became an officer of Avery Dennison Corp, listed on the New York Stock Exchange as NYSE:AVY, following a triggering event dated November 3, 2026.
Da-Wai Hu, Executive Vice President and General Counsel of Live Nation Entertainment, Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 4, 2026, reflecting a triggering event date of November 2, 2026.
John L. Slebir, Chief Legal Officer of ARS Pharmaceuticals, Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing no securities beneficially owned as of the event date of October 26, 2026.
Robert Wong, VP and Chief Accounting Officer of Retension Pharmaceuticals, Inc., reported the grant of 25,000 stock options on November 2, 2026, in a statement of changes in beneficial ownership filed with the SEC on November 4, 2026.
Director Robert Garechana filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 1,938 restricted stock units in InvenTrust Properties Corp. (NYSE:IVT).
Please wait processing your request...